Eli Lilly to acquire Morphic in $3.2bn deal to expand integrin therapy development
In a major strategic move, Eli Lilly and Company (NYSE: LLY) has announced a definitive agreement to acquire Morphic Holding, Inc. (NASDAQ: MORF), a biopharmaceutical ... Read More
Novo Nordisk announces $4.1bn investment in new North Carolina manufacturing facility
Novo Nordisk, a global leader in pharmaceutical manufacturing, has unveiled plans to invest $4.1 billion (approximately 27 billion Danish kroner) to establish a second fill ... Read More